Amyloidosis Therapeutics - Pipeline Assessment and

Market Forecasts to 2019

On 5th December 2014

Summary
The industry analysis specialist, has released its new report, Amyloidosis Therapeutics Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of
information and analysis on the global Amyloidosis Therapeutics market. The report identifies
the key trends shaping and driving the global Amyloidosis Therapeutics market. The report also
provides insights on the prevalent competitive landscape and the emerging players expected to
significantly alter the market positioning of the current market leaders. Most importantly, the
report provides valuable insights on the pipeline products within the global Amyloidosis
Therapeutics sector. This report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by GlobalDatas team of
industry experts.

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-amyloidosis-therapeutics-pipeline-assessment-and-market-forecasts135212

Scope
The report provides information on the key drivers and challenges of the Amyloidosis
Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Amyloidosis
Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Amyloidosis
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Amyloidosis Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Amyloidosis Therapeutics
market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Amyloidosis Therapeutics market.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Amyloidosis Therapeutics market in
future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
partnerships.
- Whats the next big thing in the global Amyloidosis Therapeutics market landscape? Identify,
understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table of Content
2 Amyloidosis Therapeutics - Introduction
2.1 Overview
2.2 Types of Amyloidosis
2.3 Pathophysiology of Amyloidosis
2.3.1 Pathophysiology of AL Amyloidosis
2.3.2 Pathophysiology of AA Amyloidosis
2.3.3 Pathophysiology of AF Amyloidosis
2.3.4 Pathophysiology of A2M Amyloidosis
2.3.5 Pathophysiology of Senile Amyloidosis
2.4 Epidemiology of Amyloidosis
2.4.1 Epidemiology of AL Amyloidosis
2.4.2 Epidemiology of AA Amyloidosis
2.4.3 Epidemiology of AF Amyloidosis
2.4.4 Epidemiology of A2M Amyloidosis
2.4.5 Epidemiology of Senile Amyloidosis
2.5 Etiology of Amyloidosis
2.6 Risk Factors for Development of Amyloidosis
2.7 Signs and Symptoms of Amyloidosis
2.7.1 Kidney (AL, AA)
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.7.2 Heart (AL, AF, Senile)

2.7.3 Liver (AL, AA, AF)
2.7.4 Skin (AL, AA)
2.7.5 Gastrointestinal tract (Common in all Types)
2.7.6 Nervous System (Prominent in AF)
2.7.7 Endocrine
2.7.8 Joints, Bones, and Muscles
2.7.9 Respiratory System
2.7.10 Hematopoietic System
2.7.11 Other
2.8 Diagnosis of Amyloidosis
2.8.1 Physical Examination
2.8.2 Biopsy
2.8.3 Blood Tests
2.8.4 Urine Tests
2.8.5 Imaging Techniques
2.9 Treatment and Management Pattern of Amyloidosis
2.9.1 Treatment of AL Amyloidosis
2.9.2 Treatment of AA Amyloidosis
2.9.3 Treatment of AF Amyloidosis
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.9.4 Treatment of A2M Amyloidosis

2.9.5 Treatment of Senile Amyloidosis
2.10 Prognosis of Amyloidosis
2.11 GlobalData Pipeline Report Guidance
3 Amyloidosis Therapeutics - Market Characterization
3.1 Amyloidosis Therapeutics Market Size (2006-2011) - Global
3.2 Amyloidosis Therapeutics Market Forecast (2011-2019) - Global
3.3 Amyloidosis Therapeutics Market Size (2006-2011) - The US
3.4 Amyloidosis Therapeutics Market Forecast (2011-2019) - The US
3.5 Amyloidosis Therapeutics Market Size (2006-2011) - France
3.6 Amyloidosis Therapeutics Market Forecast (2011-2019) - France
3.7 Amyloidosis Therapeutics Market Size (2006-2011) - Germany
3.8 Amyloidosis Therapeutics Market Forecast (2011-2019) - Germany
3.9 Amyloidosis Therapeutics Market Size (2006-2011) - Italy
3.10 Amyloidosis Therapeutics Market Forecast (2011-2019) - Italy
3.11 Amyloidosis Therapeutics Market Size (2006-2011) - Spain
3.12 Amyloidosis Therapeutics Market Forecast (2011-2019) - Spain
3.13 Amyloidosis Therapeutics Market Size (2006-2011) - The UK
3.14 Amyloidosis Therapeutics Market Forecast (2011-2019) - The UK
3.15 Amyloidosis Therapeutics Market Size (2006-2011) - Japan
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

3.16 Amyloidosis Therapeutics Market Forecast (2011-2019) - Japan

3.17 Drivers and Barriers for the Amyloidosis Market
3.17.1 Amyloidosis Therapeutics Market Drivers
3.17.2 Amyloidosis Therapeutics Market Barriers
3.18 Opportunity and Unmet Need
4 Amyloidosis Therapeutics - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profiles for the Major Off-label Marketed Products in the Amyloidosis Therapeutics
Market
4.3.1 Chemotherapeutic Agents
4.3.2 Steroids
4.3.3 Immunomodulator
4.3.4 New Agent
4.4 Key Takeaway
5 Amyloidosis Therapeutics - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Amyloidosis Therapeutics - Pipeline Assessment by Phase of Development
5.3.1 Amyloidosis Therapeutics - Recently Approved Drug
5.3.2 Amyloidosis Therapeutics - Phase III Pipeline
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

5.3.3 Amyloidosis Therapeutics - Phase II Pipeline

5.3.4 Amyloidosis Therapeutics - Phase I Pipeline
5.3.5 Amyloidosis Therapeutics - Pre-clinical Pipeline
5.4 Amyloidosis Therapeutics - Pipeline by Mechanism of Action
5.5 Technology Trends Analytical Framework
5.6 Recently Approved Drug
5.6.1 Vyndaqel
5.7 Most Promising Drugs Under Clinical Development
5.7.1 Kiacta
5.8 Key Takeaway
6 Amyloidosis Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Region/Country (US, EU5 and Japan)
6.2 Clinical Trials by Phase of Clinical Development
6.3 Clinical Trials by Trial Status
6.4 Prominent Sponsors
6.5 Brief Profiles of Top Companies Participating in Therapeutic Clinical Trials
7 Amyloidosis Therapeutics - Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Future Market Competition Scenario
8 Amyloidosis Therapeutics - Future Players
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

8.1 Introduction
8.2 Company Profiles
8.2.1 Pfizer Inc.
8.2.2 Bellus Health Inc.
9 Amyloidosis Therapeutics - Licensing and Partnership Deals
10 Amyloidosis Therapeutics - Appendix
10.1 Market Definitions
10.2 Acronyms
10.3 Research Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Forecasting
10.3.4 Primary Research
10.3.5 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography

List Of Tables
Table 1: Amyloid Fibril Protein and Precursor

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table 2: Major Organs Involved in Most Common Types of Amyloidosis

Table 3: Amyloidosis Therapeutics Market, Global, Revenue ($bn), 2006-2011
Table 4: Amyloidosis Therapeutics, Market, Global, Forecast ($bn), 2011-2019
Table 5: Amyloidosis Therapeutics Market, The US, Revenue ($bn), 2006-2011
Table 6: Amyloidosis Therapeutics Market, The US, Forecasts ($bn), 2011-2019
Table 7: Amyloidosis Therapeutics Market, France, Revenue ($m), 2006-2011
Table 8: Amyloidosis Therapeutics Market, France, Forecasts ($m), 2011-2019
Table 9: Amyloidosis Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 10: Amyloidosis Therapeutics Market, Germany, Forecasts ($m), 2011-2019
Table 11: Amyloidosis Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 12: Amyloidosis Therapeutics Market, Italy, Forecasts ($m), 2011-2019
Table 13: Amyloidosis Therapeutics Market, Spain, Revenue ($m), 2006-2011
Table 14: Amyloidosis Therapeutics Market, Spain, Forecasts ($m), 2011-2019
Table 15: Amyloidosis Therapeutics Market, The UK, Revenue ($m), 2006-2011
Table 16: Amyloidosis Therapeutics Market, The UK, Forecasts ($m), 2011-2019
Table 17: Amyloidosis Therapeutics Market, Japan, Revenue ($m), 2006-2011
Table 18: Amyloidosis Therapeutics Market, Japan, Forecasts ($m), 2011-2019
Table 19: Amyloidosis Therapeutics - Recently Approved Drug
Table 20: Amyloidosis Therapeutics - Phase III and Approved Pipeline, 2011
Table 21: Amyloidosis Therapeutics - Phase II Pipeline, 2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table 22: Amyloidosis Therapeutics - Phase I Pipeline, 2011

Table 23: Amyloidosis Therapeutics - Pre-clinical Pipeline, 2011
Table 24: Amyloidosis Therapeutics Market - Most Promising Drugs Under Clinical
Development, 2011
Table 25: Amyloidosis Therapeutics - Clinical Trials by Country, 2011
Table 26: Amyloidosis Therapeutics, Major Markets - Clinical Trials by Phase, 2011
Table 27: Amyloidosis Therapeutics, Major Markets, Clinical Trials by Development Status, 2011
Table 28: Amyloidosis Therapeutics, Major Markets, Prominent Sponsors, 2011
Table 29: Amyloidosis Therapeutics, Major Markets, Clinical Trials of Top Companies by Phase,
2011
Table 30: Pfizer Inc. - Amyloidosis Pipeline, 2011
Table 31: Bellus Health - Amyloidosis Pipeline, 2011
Table 32: Amyloidosis Therapeutics Market - Future Players

List Of Figures
Figure 1: Amyloidosis on Face
Figure 2: Amyloidosis Therapeutics Market, Global, Revenue ($bn), 2006-2011
Figure 3: Amyloidosis Therapeutics Market, Global, Forecast ($bn), 2011-2019
Figure 4: Amyloidosis Therapeutics Market, The US, Revenue ($bn), 2006-2011
Figure 5: Amyloidosis Therapeutics Market, The US, Forecast ($bn), 2011-2019
Figure 6: Amyloidosis Therapeutics Market, France, Revenue ($m), 2006-2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 7: Amyloidosis Therapeutics Market, France, Forecast ($m), 2011-2019

Figure 8: Amyloidosis Therapeutics Market, Germany, Revenue ($m), 2006-2011
Figure 9: Amyloidosis Therapeutics Market, Germany, Forecast ($m), 2011-2019
Figure 10: Amyloidosis Therapeutics Market, Italy, Revenue ($m), 2006-2011
Figure 11: Amyloidosis Therapeutics Market, Italy, Forecast ($m), 2011-2019
Figure 12: Amyloidosis Therapeutics Market, Spain, Revenue ($m), 2006-2011
Figure 13: Amyloidosis Therapeutics Market, Spain, Forecast ($m), 2011-2019
Figure 14: Amyloidosis Therapeutics Market, The UK, Revenue ($m), 2006-2011
Figure 15: Amyloidosis Therapeutics Market, The UK, Forecast ($m), 2011-2019
Figure 16: Amyloidosis Therapeutics Market, Japan, Revenue ($m), 2006-2011
Figure 17: Amyloidosis Therapeutics Market, Japan, Forecast ($m), 2011-2019
Figure 18: Opportunity and Unmet Need in the Amyloidosis Therapeutics Market, 2011
Figure 19: Strategic Competitor Assessment, 2011
Figure 20: Amyloidosis Therapeutics Market - Pipeline by Phase of Development, 2011
Figure 21: Amyloidosis Therapeutics - Clinical Pipeline by Mechanism of Action, 2011
Figure 22: Technology Trends Analytics Framework, 2011
Figure 23: Technology Trends Analytics Framework - Description, 2011
Figure 24: Amyloidosis Therapeutics - Clinical Trials by Country, 2011
Figure 25: Amyloidosis Therapeutics, Major Markets - Clinical Trials by Phase, 2011
Figure 26: Amyloidosis Therapeutics, Major Markets, Clinical Trials by Development Status,
2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 27: Amyloidosis Therapeutics, Major Markets, Overall Sponsors, 2011

Figure 28: Amyloidosis Therapeutics, Major Markets, Prominent Sponsors, 2011
Figure 29: Amyloidosis Therapeutics, Major Markets, Clinical Trials of Top Companies by Phase,
2011
Figure 30: Amyloidosis Therapeutics Market, Drivers and Restraints 2011
Figure 31: Implications for Future Market Competition in the Amyloidosis Therapeutics Market,
2011
Figure 32: Amyloidosis Therapeutics Market - Pipeline by Company, 2011
Figure 33: GlobalData Market Forecasting Model

Report Price:

Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Related Reports:
Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018
Cushings Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market
Forecasts to 2019
Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Liposarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com
About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

To know more on Amyloidosis Therapeutics - Pipeline Assessment and Market

Forecasts to 2019
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

http://www.jsbmarketresearch.com/healthcare-medical/r-amyloidosistherapeutics-pipeline-assessment-and-market-forecasts-135212

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/